期刊文献+

异基因造血干细胞移植术后乙型肝炎的临床特点 被引量:4

Clinical features of the patients with hepatitis B after allo-genetic hemopoietic stem cell transplantation
原文传递
导出
摘要 目的探讨异基因造血干细胞移植患者乙型肝炎的临床表现、病理、自然史。方法总结合并HBV感染的异基因造血干细胞移植患者10例,其乙型肝炎发病时临床和肝组织病理资料。血清丙氨酸氨基转移酶(ALT)、γ谷氨酰转肽酶(GGT)采用速率法,血清总胆红素(TBIL)采用终点比色法检测;乙型肝炎病毒血清标志物采用酶免疫测定(EIA),HBVDNA定量测定采用聚合酶链反应(PCR)试剂盒。其中8例进行了肝组织活检。结果(1)5例患者有慢性乙型肝炎病史,5例患者有乙型肝炎家族史,4例患者有HBV暴露史。(2)移植前10例患者肝功能指标包括ALT、TBIL、GGT均正常,而在乙型肝炎发作时上述指标均显著升高。(3)移植前受者的乙型肝炎免疫性检测为1例患者HBsAg阳性、HBeAg阳性、抗-HBc阳性;1例患者抗-HBs阳性、抗-HBc阳性;3例患者仅抗-HBc阳性;4例患者HBsAg阳性、抗-HBe阳性、抗-HBc阳性;1例患者仅抗-HBs阳性。(4)3例患者肝脏病理学诊断为纤维化瘀胆性肝炎,4例患者诊断为慢性乙型肝炎,1例患者诊断为急性乙型肝炎。(5)在随访终点时,5例患者死于重型肝炎,1例患者死于肺炎,3例患者发展为慢性乙型肝炎,1例患者痊愈。结论(1)HSCT术后乙型肝炎患者常有乙型肝炎病史、乙型肝炎家族史或HBV暴露史。(2)HSCT乙型肝炎患者的临床特点、病理、自然史不同于正常免疫状态的乙型肝炎患者。 Objective To investigate clinical signs, liver histology and natural history of allogenetic hemopoietic stem cell transplantation patients with hepatitis B. Methods Clinical data of 10 cases with hepatitis B after allo-genetic hemopoietic stem cell transplantation were summarized and analyzed. These cases were subjected to liver biochemical tests, HBV serologic assays (ELISA) and HBV DNA assays. 8 patients were taken liver biopsy. Results Five patients had hepatitis B history , five patients had hepatitis B family history and four patients had exposed to HBV. Liver functions were remarkably abnormal for patients with hepatitis B after allo-genetic hemopoietic stem cell transplantation. Three patients were diagnosed fibrosing cholestatic hepatitis, four patients were diagnosed chronic hepatitis B and one patients was acute hepatitis B by liver histology. Five patients died for liver failure and three patients developed chronic hepatitis B in the end of follow-up. Conclusions ( 1 ) Most patients with hepatitis B after HSCT had hepatitis B history or hepatitis B family history or had exposed to HBV. (2) It may be different for the clinical and liver histological data and natural history of hepatitis B between hemopoietic stem cell transplantation patients with hepatitis B and immunocompetent patients.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2006年第4期331-334,共4页 Chinese Journal of Laboratory Medicine
关键词 造血干细胞移植 肝炎 乙型 纤维化 Hematopoietic stem cell transplantation Hepatitis B Fibrosis
  • 相关文献

参考文献9

  • 1Bortin MM,Horowitz MM,Gale RP,et al.Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s.JAMA,1992,268:607-612.
  • 2Hui CK,Lie A,Au WY,et al.A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation.Blood,2005,106:464-469.
  • 3中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14006
  • 4庄辉.慢性乙型肝炎病毒感染及其防治[J].中华肝脏病杂志,2005,13(5):324-325. 被引量:35
  • 5Davies SE,Portmann BC,O'Grady JG,et al.Hepatic histological findings after transplantation for chronic hepatitis B virus infection,including a unique pattern of fibrosing cholestatic hepatitis.Hepatology,1991,13:150-157.
  • 6Gane E,Pilmore H.Management of chronic viral hepatitis before and after renal transplantation.Transplantation,2002,74:427-437.
  • 7Brechot C,Thiers V,Kremsdorf D,el al.Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:clinically significant or purely "occult"? Hepatology,2001,34:194-203.
  • 8Goyama S,Kanda Y,Nannya Y,et al.Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation.Leuk Lymphoma,2002,43:2159-2163.
  • 9Onozawa M,Hashino S,Izumiyama K,et al.Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection.Transplantation,2005,79:616-619.

二级参考文献12

  • 1Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B:2000-summary of a workshop. Gastroenterology, 2001, 120: 1828-1853.
  • 2Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology, 1990, 99: 805-810.
  • 3McMahon B J, Holck P, Bulkow L, et al. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med, 2001, 135: 759-768.
  • 4Hadziyannis S J, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res,2001, 52: 91-98.
  • 5Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol, 1994, 68: 8102-8110.
  • 6McMahon BJ. Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: are they really "off the hook"? Hepatology,1998, 28: 265-267.
  • 7Lok AS, McMahon B J; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology, 2004, 39: 857-861.
  • 8Harpaz R, McMahon B J, Margolis HS, et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis, 2000, 181: 413-418.
  • 9Chang MH, Chen C J, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med,1997, 336: 1855-1859.
  • 10龚晓红,刘立荣,贾蕾,李阳桦,邢玉兰,王全意.北京市新生儿接种乙型肝炎疫苗的流行病学效果评价[J].中华肝脏病杂志,2003,11(4):201-202. 被引量:22

共引文献14029

同被引文献13

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部